ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Comparison of Side Effects of Morphine and Hydromorphone PCA

This study has been completed.

Sponsored by: Columbia University
Information provided by: Columbia University
ClinicalTrials.gov Identifier: NCT00385541
  Purpose

Both morphine and hydromorphone are pain medications commonly used after surgery. It is thought at our institution that hydromorphone causes less side effects but this has not been studied. We propose to treat our patients with either morphine or hydromorphone and determine how much nausea, vomiting, and itching they have with each drug


Condition Intervention Phase
Post Operative Pain
Post Operative Side Effects of Narcotic Pain Medications
Drug: Morphine PCA
Drug: Hydromorphone PCA
Phase IV

MedlinePlus related topics:   Itching    Nausea and Vomiting   

Drug Information available for:   Hydromorphone    Hydromorphone hydrochloride   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Active Control, Parallel Assignment, Pharmacodynamics Study
Official Title:   Comparison of Morphine and Hydromorphone PCA

Further study details as provided by Columbia University:

Primary Outcome Measures:
  • Nausea [ Time Frame: 8 hours after surgery ]

Secondary Outcome Measures:
  • Pruritis, pain report NRS, vomiting, sedation [ Time Frame: 8 hours after surgery ]

Enrollment:   50
Study Start Date:   November 2003
Study Completion Date:   October 2007

Arms Assigned Interventions
A: Active Comparator
Patients receive morphine 1mg/ml as pca after surgery
Drug: Morphine PCA
Morphine 1mg/ml, dose 1ml, lockout 6 minutes, max 10ml
Drug: Hydromorphone PCA
hydromorphone PCA 0.2mglml, dose 1ml, lockout 6min, max 10ml

  Eligibility
Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • patients scheduled for abdominal surgery requiring post-operative PCA
  • ASA = I or II

Exclusion Criteria:

  • preoperative pain or use of pain medication
  • narcotic allergy
  • morbid obesity (BMI > 30)
  • diagnosis of sleep apnea
  • hepatic or renal disease
  • use of medications that would affect narcotic pharmacodynamics
  • preoperative nausea, vomiting, or pruritis
  • diagnosis of alcoholism
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00385541

Locations
United States, New York
Columbia Presbyterian Hospital    
      New York, New York, United States, 10032

Sponsors and Collaborators
Columbia University

Investigators
Principal Investigator:     Pamela Flood, MD     Columbia University Medical Center    
  More Information


Study ID Numbers:   AAAA2949(Y3M01)
First Received:   October 5, 2006
Last Updated:   October 29, 2007
ClinicalTrials.gov Identifier:   NCT00385541
Health Authority:   United States: Institutional Review Board

Keywords provided by Columbia University:
pain  
morphine  
hydromorphone  
nausea
vomiting
pruritis

Study placed in the following topic categories:
Hydromorphone
Pruritus
Morphine
Signs and Symptoms
Vomiting
Postoperative Complications
Nausea
Pain
Pain, Postoperative

Additional relevant MeSH terms:
Pathologic Processes
Sensory System Agents
Therapeutic Uses
Physiological Effects of Drugs
Central Nervous System Depressants
Narcotics
Peripheral Nervous System Agents
Analgesics
Central Nervous System Agents
Pharmacologic Actions
Analgesics, Opioid

ClinicalTrials.gov processed this record on October 29, 2008




Links to all studies - primarily for crawlers